English Polski
Vol 19 (2024): Continuous Publishing
Original paper
Published online: 2024-04-08

open access

Page views 148
Article views/downloads 60
Get Citation

Connect on Social Media

Connect on Social Media

Echocardiographic Parameters and Dyspnea During Treatment of Acute Decompensated Heart Failure

Kamil Bugała1, Piotr Bijak1, Leszek Drabik2, Wojciech Płazak2
DOI: 10.5603/fc.97096


Introduction. Decongestion therapy of acute decompensated heart failure (ADHF) leads to significant haemodynamic and heart rate changes. The purpose of the study was to evaluate the impact of decongestion therapy and heart rate reduction on changes in echocardiographic parameters in patients hospitalized due to ADHF.

Material and methods. In 34 consecutive adult patients (41.2% females, mean age 70.2 ± 10.8 years) who required hospitalization due to ADHF, an echocardiographic assessment was performed upon admission and at discharge together with clinical and laboratory evaluation.

Results. Significant reductions in body weight (84.22 ± 17.46 vs. 78.72 ± 16.95 kg, p < 0,001), heart rate (86.21 ± 15.7 vs. 75.72 ± 11.01 bpm, p < 0.001) and NT-proBNP level (7530.22 ± 5192.52 vs. 3270.32 ± 2947.26 pg/mL, p = 0.001) were found. In the group of patients with a weight reduction of at least 5 kg, a significant decrease in dyspnoea severity was assessed with 0–100 points VAS scale (at admission/discharge ΔVAS 42.14 ± 13.68 vs. 30.00 ± 12.79, p = 0.04), tricuspid regurgitation peak gradient (ΔTRPG 7.53 ± 9.36 vs. 1.91 ± 7.48 mm Hg, p = 0.05) and mitral regurgitation severity (ΔMR VC 1.21 ± 0.65 vs. 0.66 ± 0.77 mm, p = 0.05) were observed. The subgroup of patients with heart rate reduction over 10 bpm exhibited a significant increase in left ventricular (LV) ejection fraction (HR reduction > 10 bpm: at admission 30.56 ± 13.96; at discharge 38.69 ± 13.29 vs. HR reduction < 10 bpm 42.64 ± 14.95; 41.91 ± 13.46 %, p = 0.02), and LV outflow velocity time integral (HR reduction > 10 bpm: at admission 12.61 ± 3.64; at discharge 15.55 ± 4.88 vs. HR reduction < 10 bpm: 16.18 ± 5.64; 15.04 ± 4.45 cm, p = 0.04).

Conclusions. Treatment of fluid overload in ADHF results mainly in dyspnoea reduction, mitral regurgitation decrease and pulmonary pressure lowering. Heart rate reduction is followed by a significant increase in LV stroke volume and LV ejection fraction. Such echocardiographic changes are expected during successful ADHF treatment. Their absence may direct the attention of the attending physician to the need for more aggressive treatment or a worse prognosis for the patients.

Article available in PDF format

View PDF (Polish) Download PDF file


  1. Kurmani S, Squire I. Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep. 2017; 14(5): 385–392.
  2. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  3. Papadimitriou L, Georgiopoulou VV, Kort S, et al. Echocardiography in acute heart failure: current perspectives. J Card Fail. 2016; 22(1): 82–94.
  4. Rubiś P, Drabik L, Kopeć G, et al. The prognostic role of exercise echocardiography in heart failure. Kardiol Pol. 2011; 69(7): 656–663.
  5. Ramasubbu K, Deswal A, Chan W, et al. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012; 18(10): 792–798.
  6. Rosario LB, Stevenson LW, Solomon SD, et al. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol. 1998; 32(7): 1819–1824.
  7. Bugała K, Rubiś P, Hołda MK, et al. Mitral regurgitation severity dynamic during acute decompensated heart failure treatment. Int J Cardiovasc Imaging. 2021 [Epub ahead of print].
  8. Böhm M, Swedberg K, Komajda M, et al. SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010; 376(9744): 886–894.
  9. Yumita Y, Nagatomo Y, Takei M, et al. Personalized target heart rate for patients with heart failure and reduced ejection fraction. J Pers Med. 2022; 12(1).
  10. Kitai T, Grodin JL, Mentz RJ, et al. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. Eur J Heart Fail. 2017; 19(2): 241–249.
  11. Peschanski N, Harouki N, Soulie M, et al. Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction. ESC Heart Fail. 2021; 8(2): 1085–1095.
  12. Bahouth F, Elias A, Ghersin I, et al. The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction. ESC Heart Fail. 2022; 9(1): 585–594.
  13. Vollmert T, Hellmich M, Gassanov N, et al. Heart rate at discharge in patients with acute decompensated heart failure is a predictor of mortality. Eur J Med Res. 2020; 25(1): 47.
  14. Shirotani S, Jujo K, Abe T, et al. Prognostic impact of landiolol in patients with acute heart failure and atrial fibrillation with rapid ventricular rates: a pilot observational study. Pharmacology. 2022; 107(11-12): 601–607.
  15. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998; 7(3): 200–204.
  16. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  17. Galderisi M, Cosyns B, Edvardsen T, et al. 2016–2018 EACVI Scientific Documents Committee, 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017; 18(12): 1301–1310.
  18. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 233–270.
  19. Bui AL, Grau-Sepulveda MV, Hernandez AF, et al. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. Am Heart J. 2013; 165(4): 567–574.e6.
  20. Rosa AB, Domingo PF, Francisco GS, et al. Red Española de Insuficiencia Cardiaca researchers (REDINSCOR II). Prognostic value of discharge heart rate in acute heart failure patients: more relevant in atrial fibrillation? Int J Cardiol Heart Vasc. 2020; 26: 100444.
  21. Greene SJ, Vaduganathan M, Wilcox JE, et al. EVEREST Trial Investigators. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. JACC Heart Fail. 2013; 1(6): 488–496.
  22. Rao K, Fisher ML, Robinson S, et al. Effect of chronic changes in heart rate on congestive heart failure. J Card Fail. 2007; 13(4): 269–274.
  23. Tan C, Rubenson D, Srivastava A, et al. Left ventricular outflow tract velocity time integral outperforms ejection fraction and Doppler-derived cardiac output for predicting outcomes in a select advanced heart failure cohort. Cardiovasc Ultrasound. 2017; 15(1): 18.
  24. Kociol RD, McNulty SE, Hernandez AF, et al. NHLBI Heart Failure Network Steering Committee and Investigators. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail. 2013; 6(2): 240–245.
  25. Aronson D, Darawsha W, Atamna A, et al. Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure. J Card Fail. 2013; 19(10): 665–671.
  26. Hayasaka K, Matsue Y, Kitai T, et al. Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure. Eur Heart J Cardiovasc Imaging. 2021; 22(2): 203–209.